Brief: Essa Pharma Provides Corporate Update And Reports Financial Results For Fiscal Second Quarter Ended March 31, 2022
10/05/2022 12:12
May 10 (Reuters) - ESSA Pharma Inc EPIX.O :
* ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS
FINANCIAL
RESULTS FOR FISCAL SECOND QUARTER ENDED MARCH 31, 2022
* ESSA PHARMA INC - QTRLY $0.25 LOSS PER COMMON SHARE
* ESSA PHARMA INC - CASH POSITION IS EXPECTED TO BE
SUFFICIENT TO
FUND CURRENT AND PLANNED OPERATIONS THROUGH 2024
Source text for Eikon: ID:nCNW1FyD6a
Further company coverage: EPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ESSA Pharma
See all newsBrief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: ESSA Pharma Provides Update On Its Application To The Supreme Court Of British Columbia For Amended Interim Order
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics